The combination of granulocyte-monocyte apheresis and vedolizumab: A new treatment option for ulcerative colitis?

Iago Rodriguez-LagoJosé M BenítezLaura SempereEsteban Sáez-GonzálezManuel Barreiro-de AcostaJone O de ZárateJosé L Cabriada

Published in: Journal of clinical apheresis (2019)

This small case series suggests that combining GMA with VDZ could be a treatment option in selected cases of UC with an inadequate response to this biologic agent.

Keyphrases

ulcerative colitis
rheumatoid arthritis
peripheral blood
dendritic cells